Axa’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Sell |
83,839
-20,205
| -19% | -$954K | 0.01% | 610 |
|
|
2025
Q1 | $4.06M | Sell |
104,044
-134
| -0.1% | -$5.24K | 0.01% | 593 |
|
|
2024
Q4 | $5.64M | Sell |
104,178
-164
| -0.2% | -$8.88K | 0.02% | 511 |
|
|
2024
Q3 | $5.26M | Buy |
104,342
+28
| +0% | +$1.41K | 0.02% | 532 |
|
|
2024
Q2 | $4.59M | Buy |
104,314
+59
| +0.1% | +$2.59K | 0.01% | 548 |
|
|
2024
Q1 | $5.24M | Buy |
104,255
+29
| +0% | +$1.46K | 0.02% | 546 |
|
|
2023
Q4 | $6.29M | Sell |
104,226
-19,165
| -16% | -$1.16M | 0.02% | 496 |
|
|
2023
Q3 | $7.03M | Sell |
123,391
-31,541
| -20% | -$1.8M | 0.02% | 467 |
|
|
2023
Q2 | $7.9M | Sell |
154,932
-146,422
| -49% | -$7.47M | 0.03% | 454 |
|
|
2023
Q1 | $6.45M | Sell |
301,354
-103,930
| -26% | -$2.22M | 0.02% | 504 |
|
|
2022
Q4 | $4.26M | Buy |
+405,284
| New | +$4.26M | 0.02% | 645 |
|